A Pilot Study to Assess the Activity of Demethylation Therapy in Patients With HPV Positive Compared With HPV Negative Head and Neck Squamous Cell Carcinoma (HNSCC)
Phase of Trial: Phase II
Latest Information Update: 17 Jan 2018
At a glance
- Drugs Azacitidine (Primary)
- Indications Head and neck cancer; Squamous cell cancer
- Focus Therapeutic Use
- 12 Jan 2018 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 12 Jan 2018 Planned primary completion date changed from 1 Jul 2017 to 1 Jul 2018.
- 10 Jun 2017 Biomarkers information updated